Anti-apoptotic protection afforded by cardioplegic celsior and histidine buffer solutions to hearts subjected to ischemia and ischemia/reperfusion

Journal of Cellular Biochemistry

Volumn 112, Issue 12, 2011, Pages 3872-3881

  Alves, Marco G ^a,b   MacHado, Nuno G ^a   Sardão, Vilma A ^a   Carvalho, Rui A ^a,b   Oliveira, Paulo J ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Apoptosis; Heart preservation; Ischemia; Reperfusion

Indexed keywords

BUFFER; CASPASE 3; CASPASE 8; CASPASE 9; CELSIOR; FAS LIGAND; FLICE INHIBITORY PROTEIN; PROTEIN BAX; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE PRESSURE; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PRESERVATION; HEART PROTECTION; HEART RATE; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BUFFERS; CARDIOPLEGIC SOLUTIONS; FEMALE; HISTIDINE; MALE; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 80055000219     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23320     Document Type: Article

References (40)

1. Ackemann J, Gross W, Mory M, Schaefer M, Gebhard MM,. 2002. Celsior versus custodiol: Early postischemic recovery after cardioplegia and ischemia at 5 degrees C. Ann Thorac Surg 74: 522-529. (Pubitemid 34838862)
2. Albacker TB, Carvalho G, Schricker T, Lachapelle K,. 2007. Myocardial protection during elective coronary artery bypass grafting using high-dose insulin therapy. Ann Thorac Surg 84: 1920-1927; discussion 1920-7. (Pubitemid 350122414)
3. Alves M, Oliveira P, Carvalho R,. 2009. Mitochondrial preservation in celsior versus histidine buffer solution during cardiac ischemia and reperfusion. Cardiovasc Toxicol 9: 185-193.
4. Alves MG, Oliveira PJ, Carvalho RA,. 2011a. Substrate selection in hearts subjected to ischemia/reperfusion: Role of cardioplegic solutions and gender. NMR Biomed. DOI: 10.1002/nbm.1640.
5. Alves MG, Soares AF, Carvalho RA, Oliveira PJ,. 2011b. Sodium hydrosulfide improves the protective potential of the cardioplegic histidine buffer solution. Eur J Pharmacol 654: 60-67.
6. Arima Y, Nitta M, Kuninaka S, Zhang D, Fujiwara T, Taya Y, Nakao M, Saya H,. 2005. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem 280: 19166-19176. (Pubitemid 41379623)
7. Bouchier-Hayes L, Lartigue L, Newmeyer DD,. 2005. Mitochondria: Pharmacological manipulation of cell death. J Clin Invest 115: 2640-2647. (Pubitemid 41434387)
8. Bradford MM,. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
9. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR,. 2004. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014. (Pubitemid 38209704)
10. Gateau-Roesch O, Argaud L, Ovize M,. 2006. Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 70: 264-273.
11. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL,. 1994. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628. (Pubitemid 24309885)
12. Griffin JL, White LT, Lewandowski ED,. 2000. Substrate-dependent proton load and recovery of stunned hearts during pyruvate dehydrogenase stimulation. Am J Physiol Heart Circ Physiol 279: H361-H367. (Pubitemid 30616679)
13. Han YX, Zhang SH, Wang XM, Wu JB,. 2006. Inhibition of mitochondria responsible for the anti-apoptotic effects of melatonin during ischemia-reperfusion. J Zhejiang Univ Sci B 7: 142-147.
14. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P,. 1996. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107. (Pubitemid 26041012)
15. Kang PM, Haunstetter A, Aoki H, Usheva A, Izumo S,. 2000. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 87: 118-125. (Pubitemid 30616907)
16. Korge P, Honda HM, Weiss JN,. 2002. Protection of cardiac mitochondria by diazoxide and protein kinase C: Implications for ischemic preconditioning. PNAs 99: 3312-3317. (Pubitemid 34240628)
17. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S,. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276: 20633-20640.
18. Krysko DV, Roels F, Leybaert L, D'Herde K,. 2001. Mitochondrial transmembrane potential changes support the concept of mitochondrial heterogeneity during apoptosis. J Histochem Cytochem 49: 1277-1284. (Pubitemid 32885391)
19. Latif N, Khan MA, Birks E, O'Farrell A, Westbrook J, Dunn MJ, Yacoub MH,. 2000. Upregulation of the Bcl-2 family of proteins in end stage heart failure. J Am Coll Cardiol 35: 1769-1777. (Pubitemid 30342855)
20. Liu P, Xu B, Cavalieri TA, Hock CE,. 2008. Inhibition of p53 by pifithrin-alpha reduces myocyte apoptosis and leukocyte transmigration in aged rat hearts following 24 hours of reperfusion. Shock 30: 545-551.
21. Marchenko ND, Zaika A, Moll UM,. 2000. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275: 16202-16212. (Pubitemid 30366932)
22. McCully JD, Wakiyama H, Hsieh YJ, Jones M, Levitsky S,. 2004. Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 286: H1923-H1935. (Pubitemid 38525483)
23. Mocanu MM, Yellon DM,. 2003. p53 down-regulation: A new molecular mechanism involved in ischaemic preconditioning. FEBS Lett 555: 302-306. (Pubitemid 37486045)
24. Muhlbacher F, Langer F, Mittermayer C,. 1999. Preservation solutions for transplantation. Transplant Proc 31: 2069-2070. (Pubitemid 29376529)
25. Murphy JG, Marsh JD, Smith TW,. 1987. The role of calcium in ischemic myocardial injury. Circulation 75: V15-V24.
26. Mutomba MC, Yuan H, Konyavko M, Adachi S, Yokoyama CB, Esser V, McGarry JD, Babior BM, Gottlieb RA,. 2000. Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine. FEBS Lett 478: 19-25. (Pubitemid 30462251)
27. Oliveira PJ, Marques MP, Batista de Carvalho LA, Moreno AJ,. 2000. Effects of carvedilol on isolated heart mitochondria: Evidence for a protonophoretic mechanism. Biochem Biophys Res Commun 276: 82-87.
28. Ranki HJ, Budas GR, Crawford RM, Jovanovic A,. 2001. Gender-specific difference in cardiac ATP-sensitive K(+) channels. J Am Coll Cardiol 38: 906-915. (Pubitemid 32835771)
29. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, Keen SL, Tawa P, Xanthoudakis S, Nasir J, Martindale D, Koop BF, Peterson EP, Thornberry NA, Huang J, MacPherson DP, Black SC, Hornung F, Lenardo MJ, Hayden MR, Roy S, Nicholson DW,. 1998. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ 5: 271-288. (Pubitemid 28356540)
30. Riedl SJ, Salvesen GS,. 2007. The apoptosome: Signalling platform of cell death. Nat Rev Mol Cell Biol 8: 405-413. (Pubitemid 46643237)
31. Robinet A, Hoizey G, Millart H,. 2005. PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning. Cardiovasc Res 66: 530-542. (Pubitemid 40725765)
32. Sardao VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB,. 2009. Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts. Cancer Chemother Pharmacol 64: 811-827.
33. Sayk F, Kruger S, Bechtel JF, Feller AC, Sievers HH, Bartels C,. 2004. Significant damage of the conduction system during cardioplegic arrest is due to necrosis not apoptosis. Eur J Cardiothorac Surg 25: 801-806. (Pubitemid 38481995)
34. Sumimoto R, Kamada N, Jamieson NV, Fukuda Y, Dohi K,. 1991. A comparison of a new solution combining histidine and lactobionate with UW solution and eurocollins for rat liver preservation. Transplantation 51: 589-593.
35. Takeuchi K, Cao-Danh H, Kawai A, Ohkado A, Konishi H, McGowan FX, del Nido PJ,. 1999a. Prolonged preservation of the blood-perfused canine heart with glycolysis-promoting solution. Ann Thorac Surg 68: 903-907. (Pubitemid 29526858)
36. Takeuchi K, Maida K, Tanaka S, Yoshida S, McGowan X, Jr., del Nido PJ,. 1999b. Superior myocardial protection with a new histidine-buffered crystalloid cardioplegic solution in clinical trial. Thorac Cardiovasc Surg 47: 148-152. (Pubitemid 29325694)
37. Tolba RH, Akbar S, Muller A, Glatzel U, Minor T,. 2000. Experimental liver preservation with Celsior: A novel alternative to University of Wisconsin and histidine-tryptophan-alpha-ketoglutarate solutions? Eur Surg Res 32: 142-147. (Pubitemid 30456775)
38. Toth A, Jeffers JR, Nickson P, Min JY, Morgan JP, Zambetti GP, Erhardt P,. 2006. Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 291: H52-H60.
39. Wilhelm MJ, Pratschke J, Laskowski I, Tilney NL,. 2003. Ischemia and reperfusion injury. Transplant Rev 17: 140-157. (Pubitemid 37038561)
40. Yu QJ, Si R, Zhou N, Zhang HF, Guo WY, Wang HC, Gao F,. 2008. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: A novel mechanism of insulin in cardioprotection. Apoptosis 13: 305-317.